Last Updated: November 8, 2026

ROSIGLITAZONE MALEATE AND GLIMEPIRIDE Drug Patent Profile

Name: ROSIGLITAZONE MALEATE AND GLIMEPIRIDE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Rosiglitazone Maleate And Glimepiride, and when can generic versions of Rosiglitazone Maleate And Glimepiride launch?

Rosiglitazone Maleate And Glimepiride is a drug marketed by Teva Pharms Usa and is included in one NDA.

The generic ingredient in ROSIGLITAZONE MALEATE AND GLIMEPIRIDE is glimepiride; rosiglitazone maleate. There is one drug master file entry for this compound. Additional details are available on the glimepiride; rosiglitazone maleate profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE?
What are the global sales for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE?
What is Average Wholesale Price for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE?

Summary for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE

US Patents:	0
Applicants:	1
NDAs:	1
Clinical Trials:	1
DailyMed Link:	ROSIGLITAZONE MALEATE AND GLIMEPIRIDE at DailyMed

Drug patent expirations by year for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE

Recent Clinical Trials for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Canadian Heart Research Centre	Phase 3
GlaxoSmithKline	Phase 3

See all ROSIGLITAZONE MALEATE AND GLIMEPIRIDE clinical trials

US Patents and Regulatory Information for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Pharms Usa	ROSIGLITAZONE MALEATE AND GLIMEPIRIDE	glimepiride; rosiglitazone maleate	TABLET;ORAL	078709-001	Apr 1, 2016		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Teva Pharms Usa	ROSIGLITAZONE MALEATE AND GLIMEPIRIDE	glimepiride; rosiglitazone maleate	TABLET;ORAL	078709-003	Apr 1, 2016		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Teva Pharms Usa	ROSIGLITAZONE MALEATE AND GLIMEPIRIDE	glimepiride; rosiglitazone maleate	TABLET;ORAL	078709-002	Apr 1, 2016		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Teva Pharms Usa	ROSIGLITAZONE MALEATE AND GLIMEPIRIDE	glimepiride; rosiglitazone maleate	TABLET;ORAL	078709-004	Apr 1, 2016		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Teva Pharms Usa	ROSIGLITAZONE MALEATE AND GLIMEPIRIDE	glimepiride; rosiglitazone maleate	TABLET;ORAL	078709-005	Apr 1, 2016		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.